Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, January 2003, p. 53-58, Vol. 10, No. 1
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.1.53-58.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Alterations in T-Cell Receptor Vß Repertoire of CD4 and CD8 T Lymphocytes in Human Immunodeficiency Virus-Infected Children
Monica Kharbanda, Thomas W. McCloskey, Rajendra Pahwa, Mei Sun, and Savita Pahwa*
Immunology and Inflammation Center, North Shore LIJ Research Institute, North Shore LIJ Health System, New York University School of Medicine, Manhasset, New York 11030
Received 8 January 2002/
Returned for modification 15 March 2002/
Accepted 7 October 2002

ABSTRACT
Perturbations in the T-cell receptor (TCR) Vß repertoire
were assessed in the CD4 and CD8 T lymphocytes of human immunodeficiency
virus (HIV)-infected children who were receiving therapy during
the chronic phase of infection by flow cytometry (FC) and PCR
analysis. By FC, representation of 21 TCR Vß subfamilies
was assessed for an increased or decreased percentage in CD4
and CD8 T cells, and by PCR, 22 TCR Vß subfamilies
of CD4 and CD8 T cells were analyzed by CDR3 spectratyping for
perturbations and reduction in the number of peaks, loss of
Gaussian distribution, or clonal dominance. The majority of
the TCR Vß subfamilies were examined by both methods
and assessed for deviation from the norm by comparison with
cord blood samples. The CD8-T-lymphocyte population exhibited
more perturbations than the CD4 subset, and clonal dominance
was present exclusively in CD8 T cells. Of the 55 total CD8-TCR
Vß families classified with clonal dominance by CDR3
spectratyping, only 18 of these exhibited increased expression
by FC. Patients with high numbers of CD8-TCR Vß families
with decreased percentages had reduced percentages of total
CD4 T cells. Increases in the number of CD4-TCR Vß
families with increased percentages showed a positive correlation
with skewing. Overall, changes from normal were often discordant
between the two methods. This study suggests that the assessment
of HIV-induced alterations in TCR Vß families at cellular
and molecular levels yields different information and that our
understanding of the immune response to HIV is still evolving.

INTRODUCTION
The majority of peripheral blood CD4 and CD8 T cells express
the

ß T-cell receptor (TCR), with the ß
chain represented by variable segments which are grouped into
families based on sequence homology (
16). A complete T-cell
repertoire is indicative of an intact T-cell population with
the potential to recognize a wide range of immunogens. Numerous
reports have documented changes in the TCR Vß repertoire
during human immunodeficiency virus (HIV) infection in relation
to disease progression and the effect of therapy (
4,
5,
8-
10,
19-
23). CDR3 length spectratyping (
8,
19,
21) and flow cytometric
(FC) analysis of TCR Vß families labeled with specific
monoclonal antibodies (MAbs) (
4,
7,
26) are among the most frequently
used assays for the analysis of TCR Vß repertoire
in HIV infection. The CDR3 spectratype is an indicator of the
relative proportion of cells in each TCR Vß family
with CDR3 of particular lengths, while labeling of cells with
TCR-Vß-specific MAbs provides a quantitative assessment
of the percentages of particular TCR Vß families in
T cells. Thus, evaluation of the TCR Vß repertoire
with MAbs, in combination with CDR3 spectratyping, is expected
to provide complementary information. In the present study,
we analyzed the TCR Vß repertoire in the CD4 and CD8
T cells of 22 HIV-infected children by CDR3 length analysis
and by FC.

MATERIALS AND METHODS
Patient population.
TCR Vß repertoire analyses by PCR and FC were performed
concurrently in 22 HIV-infected children with a median age of
8.5 years (25th to 75th percentile, 5.5 to 13.0 years). The
study cohort was comprised of patients in different stages of
the disease with a median CD4 count of 26% (25th to 75th percentile,
22 to 31%) and a median plasma HIV RNA virus load of 19,629
RNA copies/ml (25th to 75th percentile, 1,070 to 96,216 RNA
copies/ml). All except 2 patients were receiving antiretroviral
therapy: 1 patient was on a single drug and 5 were on two drugs,
while the remaining 14 patients were receiving

3 drugs. Peripheral
blood samples were collected during regularly scheduled visits
for routine clinical testing following the obtaining of informed
consent as per institutional review board-approved protocols.
This research was performed in compliance with all relevant
federal guidelines and institutional policies. Patient characteristics
at the time of study are shown in Table
1.
CDR3 length analysis using reverse transcription-PCR.
Peripheral blood mononuclear cells were isolated from heparinized
venous blood by ficoll-metrizoate (Lymphoprep; Nyegard, Oslo,
Norway) density gradient centrifugation. CD4 and CD8 T cells
were positively selected by using magnetic beads coated with
anti-CD4 and anti-CD8 MAbs according to the manufacturer's instructions
(Dynal, Lake Success, N.Y.). The purity of recovered cells as
assessed by FC was >98%. RNA was extracted directly from
cells coated on beads with Ultraspec RNA solution (Biotecx,
Houston, Tex.). RNA (1 to 5 µg) was reverse transcribed
with Moloney murine leukemia virus reverse transcriptase enzyme
(Gibco BRL, Grand Island, N.Y.) and TCR ß-chain C
region primer (Cß14). Multiplex PCR was performed
with forward Vß primers for TCR Vß family
1 (Vß1), -2, -3, -4, -5.1, -5.2, -6, -7, -8, -9, -11,
-12, -13.1, -13.2, -14, -15, -16, -17, -18, -20, -21, -22, -23,
and -24 and
32P-labeled CßR reverse primer in the
presence of AmpliTaq Gold DNA polymerase (PerkinElmer, Branchburg,
N.J.) as described previously (
12,
25). Vß10 and -19
were not analyzed, as they are pseudogenes (
3). PCR conditions
were as follows: 12 min of incubation at 95°C to activate
the AmpliTaq Gold enzyme, followed by 35 cycles of denaturation
at 94°C for 30 s, annealing at 55°C for 30 s, and extension
at 72°C for 1 min. At the end of 35 cycles, a final extension
was performed at 72°C for 10 min. The PCR products were
resolved on a 6% polyacrylamide gel, followed by analysis on
a Phosphorimager (Molecular Dynamics, Sunnyvale, Calif.). An
immunoscope pattern was generated by using ImageQuant software
(Molecular Dynamics), and the intensity of the signals from
CDR3 segments in each TCR Vß family was quantified.
Standards for CDR3 lengths in an unperturbed TCR Vß
repertoire were established by examining purified CD4 and CD8
populations in 10 umbilical cord blood samples obtained from
healthy women following uneventful deliveries. CDR3 length distribution
for each Vß family in cord blood CD4 and CD8 T cells
showed a Gaussian distribution. The 5th and 95th percentiles
of the numbers of peaks were calculated for each family. These
were five to nine peaks, with the exception of Vß23,
which showed three to seven peaks (data not shown). In patient
samples, TCR Vß families that exhibited a Gaussian
distribution of the CDR3 lengths were considered unperturbed.
The term skewing was used for TCR Vß families that
did not show a Gaussian distribution or had a reduction in the
number of peaks to <5 (
28). The term clonal dominance was
used for TCR Vß families that contained a peak whose
area was >50% of the total area for that family (
6,
12,
25).
FC determination of Vß family representation.
The percentage of each Vß family was quantified by four-color FC with a TCR Vß kit (kindly provided by Coulter-Immunotech, Miami, Fla.). This kit consists of premixed combinations of three anti-Vß MAbs per vial for the quantification of TCR Vß1, -2, -3, -5.1, -5.2, -5.3, -7, -8, -9, -11, -12, -13.1, -13.6, -14, -16, -17, -18, -20, -21.3, -22, and -23: one conjugated with fluorescein isothiocyanate, the second conjugated with phycoerythrin, and the third conjugated with both fluorochromes (14). These reagents were combined with MAbs directed against CD4 conjugated with phycoerythrin-cyanine 5 (Immunotech) and directed against CD8 conjugated to allophycocyanin (Caltag, Burlingame, Calif.). Samples were labeled within 6 h of phlebotomy, lysed with Immunolyse (Coulter), and fixed in 1% paraformaldehyde (Electron Microscopy Sciences, Fort Washington, Pa.). Lymphocytes were gated on CD4bright or CD8bright for the determination of Vß percentages. Normal values for the percent representation of individual Vß families within both CD4- and CD8-T-cell subsets were determined by calculating the 5th and 95th percentiles for each Vß family from 10 cord blood samples (data not shown). In patient samples, values in excess of (increase) or less than (decrease) the 5th and 95th percentiles established in cord blood T cells were considered perturbed.
Estimation of plasma viral load.
HIV RNA in plasma was quantified with the Amplicor HIV monitor kit (Roche Diagnostics, Somerville, N.J.). Sensitivity of the assay was <50 HIV RNA copies/ml of plasma.
Statistical analysis.
Statistical analysis was performed with Sigmastat Software (Jandel Scientific, San Rafael, Calif.). Distributions of data sets were checked for normality and compared by using Student's t test or the Mann-Whitney rank sum test as appropriate, with a P of <0.05 considered significant. Spearman's correlation coefficient was utilized to determine the relationships between examined parameters.

RESULTS
TCR Vß repertoire perturbations within CD4- and CD8-T-lymphocyte populations.
The TCR Vß repertoire of both the CD4- and CD8-T-cell
subsets of HIV-infected children (Tables
2 and
3, respectively)
was found to be significantly perturbed compared to the cord
blood repertoire, which served as the standard for an unaltered
repertoire.
As shown in Table
2, CDR3 spectratyping of CD4 T cells revealed
skewing in 9.7% of Vß families based upon the loss
of Gaussian distribution and reduction in the number of peaks
in the CDR3 regions of particular Vß families. There
was no evidence of clonal dominance in any Vß family
in CD4 T cells. By FC, there was evidence for both an increase
and a decrease in the percentage of CD4 T cells expressing particular
Vß families. Increased expression was detected in
13.6% (
n = 60) of TCR Vß families, and decreased expression
was observed in 8.8% (
n = 40) of TCR Vß families of
CD4 T cells. As indicated in Table
2, when data for CDR3 spectratyping
and FC were evaluated together, of the 42 CD4 TCR Vß
families that exhibited skewing (by CDR3 spectratyping), percent
TCR Vß expression by FC was increased in only five
individual TCR Vß families and was not decreased in
any.
In contrast to CD4 T cells, CD8 T cells exhibited profound alterations in the TCR Vß repertoire of HIV-infected children by all measured parameters (Table 3). Abnormalities in CD8-TCR Vß repertoire were most apparent in assays of CDR3 spectratyping, with 202 Vß families (38.2%) exhibiting skewing; of these, 55 Vß families (10.4%) exhibited clonal dominance. As seen for the CD4 T cells, FC revealed an abnormal expression of certain TCR Vß families of CD8 T cells, only some of which were deemed skewed or dominant by CDR3 length analysis. Overall, in the CD8 T-cell repertoire of all the Vß families tested in 22 HIV-infected children, 202 Vß families showed skewing by CDR3 spectratyping; of these 202 families, the percentages of 43 families were increased as determined by FC and the percentages of 6 families were decreased. Of the 55 families that showed evidence of clonal dominance by CDR3 spectratyping, 18 exhibited increased expression by FC.
By both PCR-based CDR3 length spectratyping and FC, CD8 T cells exhibited more perturbations than the CD4 subset (Fig. 1). By CDR3 spectratyping, a median number of two TCR Vß families for CD4 T cells and eight Vß families for CD8 T cells (P < 0.001) were skewed in 18 subjects. Clonal dominance was observed exclusively in the CD8 T cells. By FC as well, increases in the percent expression of particular Vß families in the CD8-T-cell compartment were greater than the increases of those within the CD4 subset (mean CD8 count 4.41 versus mean CD4 count = 2.86, P = 0.016) in 21 subjects. The absolute difference in percentages of each TCR Vß family relative to that from the cord blood was significantly greater for CD8 T lymphocytes compared to that for CD4 T lymphocytes (mean CD8 count = 1.36 versus mean CD4 count = 0.92, P < 0.001).
Relationship between TCR Vß perturbations and clinical parameters.
We investigated whether a relationship existed between the level
of perturbation in the TCR Vß repertoire and the variables
of CD4-cell count and plasma viral load. Percent CD4 was negatively
correlated with the number of CD8-TCR Vß families
showing decreased expression by FC (
r = -0.439,
P = 0.04) (Fig.
2A). No other correlations between repertoire deviation and
CD4-cell count or plasma viral load were observed. In addition,
no correlation was noted between perturbations detected by CDR3
spectratyping in the T-cell repertoire with the age of the patients,
the nature of therapy, or plasma virus load.
Correlations between different assays used to determine TCR Vß perturbations.
We sought to investigate if a relationship existed between the
number of perturbations at the molecular level determined by
CDR3 spectratyping (skewing or dominance) and the TCR Vß
usage at the cellular level as determined by FC (increase or
decrease). The number of CD8-TCR Vß families exhibiting
increases in percent expression correlated with the number of
CD4-TCR Vß families that showed increases in percent
expression (
r = 0.446,
P = 0.04) (Fig.
2B). The number of TCR
Vß families in CD4 T cells that exhibited skewing
by CDR3 spectratyping correlated with the number of CD4 Vß
families that were overexpressed by FC (
r = 0.45,
P = 0.05)
(Fig.
3A) and with the number of CD8-TCR Vß families
that were underexpressed by the FC assay (
r = 0.576,
P = 0.01)
(Fig.
3B). Within the FC assay, overexpressed CD4-TCR Vß
families and CD8-TCR Vß families correlated with each
other. Within the CDR3 spectratyping assay, the number of CD8-TCR
Vß families showing skewing correlated with the number
of Vß families demonstrating clonal dominance (
r =
0.43,
P = 0.04). The individual TCR Vß families exhibiting
perturbations, however, were usually disparate and only rarely
the same (Tables
2 and
3).

DISCUSSION
Upon antigen encounter, the response of both CD4 and CD8 cells
is deemed to be essential for mounting an efficient immune response.
In the HIV-infected children studied, marked distortions were
observed in TCR Vß repertoire in CD4 and CD8 T cells,
with more perturbations in CD8 compared to CD4 T cells, which
is in concordance with previous reports (
9,
13,
21,
22). While
increases in the percentages of particular TCR Vß
families were detected by FC in CD4 and CD8 T cells, clonal
dominance was exclusively present in the CD8-T-cell compartment
(
25), which has been previously shown to result from oligoclonal
expansions by sequence analysis (
12). A possible explanation
lies in the robustness and kinetics of the response of each
subpopulation subsequent to antigen encounter, as it has been
demonstrated that the initial proliferation of CD8 cells is
of greater magnitude than CD4 cells and of longer duration (
13);
a recent investigation of pediatric HIV infection found persistent
high-level TCR Vß-specific expansions only within
the CD8 subpopulation (
22). In the present study, increases
in percent representation of TCR Vß families in the
CD4
+ T cells were without clonotypic overrepresentation.
Our observation of an association between the number of CD4- and CD8-TCR Vß families with increased percentages leads us to speculate that these CD4 populations may have specifically responded to HIV. If so, this would support the concept that helper T cells are imperative for CD8-T-cell function, e.g., cytotoxic lymphocyte activity. Indeed, patients with tremendously depleted CD4 pools no longer possess detectable HIV-specific CD8 cells (11) while those patients capable of controlling virus in the absence of therapy exhibit strong helper activity (27). HIV-infected children with preserved or restored CD4 compartments who are given therapy are perhaps more likely to exhibit virus-specific cytotoxic-T-lymphocyte expansions compared to patients in whom this population is depleted. While increased percentages of CD4 T cells in HIV-infected children occur transiently (22), their role in influencing the antigen-specific CD8-T-cell response remains to be elucidated. One possibility is that the CD4 help given to the CD8 lymphocytes is required only during the initial phase of activation. An alternative hypothesis is that, since CD4 T cells are the primary target of HIV infection, antigen-specific activity in these cells leads to their preferential infection and deletion and the remaining cells are dysregulated due to induction of anergy or apoptosis. A third possibility is that this may indicate an oligoclonal response but not with the dominance of particular clones.
How does the TCR Vß response to HIV differ from that against other viral infections? For the response to Epstein-Barr virus, selective and massive expansion of a few dominant clones of CD8 T cells accounts for a significant proportion of the lymphocytosis observed (2). Similarly, only a limited number of clones appear to respond to measles virus (15). Importantly, neither infectious mononucleosis nor measles results in chronic persistent infection as does HIV and elicits only transient lymphocyte expansions. This is in contrast to HIV infection in which a much more heterogeneous response was observed. In an earlier study, it was found that HIV-specific lymphocytes displayed a heterogeneous TCR Vß repertoire in certain patients (14). A key factor impacting the breadth of immune response may be the duration of disease; a pathogen-inducing chronic disease may, over time, involve more Vß families than a transient infection. However, the normal mechanisms which result in focusing of the T-cell response may not be operative during HIV infection (1), which may be influenced by chronic immune activation, high mutation rate of the virus, or loss of the T-helper-cell population
It can be speculated that isolated TCR Vß perturbations may result from the partial activation of lymphocytes by HIV or the response elicited could be against other antigens. Evidence from the B-cell compartment demonstrates a highly activated cell population that produces large amounts of antibody, very little of which is specific (18). A similar phenomenon could occur in the T-cell pool as well. Indeed, a mechanism of partial activation resulting from incomplete T-lymphocyte differentiation in response to viral antigens has recently been described (24). Experiments using major histocompatibility complex peptide tetrameric complexes in combination with functional assessment will serve to clarify this issue. Another important question is whether particular clones become susceptible to apoptosis. High levels of CD8-cell apoptosis in HIV-infected children have been demonstrated previously (17).
This study has demonstrated that the information gathered from qualitative PCR methods and from quantitative FC methods for the analysis of TCR Vß repertoire is different. With many TCR Vß families exhibiting discordance in the detection of deviation from the norm between the two methods, the significance of any single result remains unclear. Our study was conducted in chronically infected children receiving therapy; a clearer picture of the changes in TCR Vß repertoire may be evident during the acute phase of response in the absence of treatment. Our understanding of the significance of assessment of the TCR Vß repertoire during HIV infection in children is still evolving.

ACKNOWLEDGMENTS
M.K. and T.W.M. contributed equally to this work.
This work was supported by Public Health Service grant NIH HD37345, AI48857, and AI28281.
We thank Maria Marecki, Herb Borrero, and Zhexiong Lian for assistance in sample preparation and Saroj Bakshi for assistance in obtaining samples.

FOOTNOTES
* Corresponding author: Savita Pahwa, M.D., North Shore LIJ Research Institute, 350 Community Dr., Manhasset, NY 11030. Phone: (516) 562-4641. Fax: (516) 562-2866. E-mail:
spahwa{at}nshs.edu.


REFERENCES
1 - Blattman, J. N., D. J. D. Sourdive, K. Murali-Krishna, R. Ahmed, and J. D. Altman. 2000. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J. Immunol. 165:6081-6090.[Abstract/Free Full Text]
2 - Callan, M. F. C., N. Steven, P. Krausa, J. D. K. Wilson, P. A. H. Moss, G. M. Gillespie, J. I. Bell, A. B. Rickinson, and A. J. McMichael. 1996. Large clonal expansions of CD8 T cells in acute infectious mononucleosis. Nat. Med. 2:906-911.[CrossRef][Medline]
3 - Connors, M., J. A. Kovacs, S. Krevat, J. C. Gea-Banacloche, M. C. Sneller, M. Flanigan, J. A. Metcalf, R. E. Walker, J. Falloon, M. Baseler, R. Stevens, I. Feuerstein, H. Masur, and H. C. Lane. 1997. HIV induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3:533-540.[CrossRef][Medline]
4 - Cossarizza, A., C. Ortolani, C. Mussini, G. Guaraldi, N. Mongiardo, V. Borghi, D. Barbieri, E. Bellesia, M. G. Franseschini, B. D. Rienzo, and C. Franceschi. 1995. Lack of selective Vß deletion in CD4 or CD8 T lymphocytes and functional integrity of TCR during acute HIV syndrome. AIDS 9:547-553.[Medline]
5 - aDouek, D. C., J. M. Brenchley, M. R. Betts, D. R. Ambrozak, B. J. Hill, Y. Okamoto, J. P. Casazza, J. Kuruppu, K. Kunstman, S. Wolinsky, Z. Grossman, M. Dybul, A. Oxenius, D. A. Price, M. Connors, and R. A. Koup. 2002. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417:95-98.[CrossRef][Medline]
6 - Eiraku, N., R. Hingorani, S. Ijichi, K. Machigashira, P. K. Gregersen, J. Monteiro, K. Usuku, S. Yashiki, S. Sonoda, M. Osame, and W. W. Hall. 1998. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotrophic virus type I-infected individuals. J. Immunol. 161:6674-6680.[Abstract/Free Full Text]
7 - Faint, J. M., D. Pilling, A. N. Akbar, G. D. Kitas, G. D. Bacon, and M. Salmon. 1999. Quantitative flow cytometry for the analysis of T cell receptor Vß chain expression. J. Immunol. Methods 225:53-60.[CrossRef][Medline]
8 - Gorochov, G., A. U. Neumann, A. Kereveur, C. Parizot, T. Li, C. Katlama, M. Karmochkine, G. Raguin, B. Autran, and P. Debre. 1998. Perturbations of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat. Med. 4:215-221.[CrossRef][Medline]
9 - Halapi, E., M. Jeddi-Tehrani, A. Blucher, R. Andersson, P. Rossi, H. Wigzell, and J. Grunewald. 1999. Diverse T-cell receptor CDR3 length patterns in human CD4+ and CD8+ T lymphocytes from newborns and adults. Scand. J. Immunol. 49:149-154.[CrossRef][Medline]
10 - Hodara, V. L., M. Jeddi-Tehrani, J. Grunewald, R. Andersson, G. Scarlatti, S. Esin, V. Holmberg, O. Libonatti, and H. Wigzell. 1993. HIV infection leads to differential expression of T-cell receptor Vß genes in CD4+ and CD8+ T cells. AIDS 7:633-638.[Medline]
11 - Kalams, S. A., and B. D. Walker. 1998. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188:2199-2204.[Free Full Text]
12 - Kharbanda, M., S. Than, V. Chitnis, M. Sun, S. Chavan, S. Bakshi, and S. Pahwa. 2000. Patterns of CD8 T cell clonal dominance in response to change in antiretroviral therapy in HIV-infected children. AIDS 14:2229-2238.[CrossRef][Medline]
13 - Maini, M. K., G. Casorati, P. Dellabona, A. Wack, and P. C. L. Beverley. 1999. T cell clonality in immune responses. Immunol. Today 20:262-266.[CrossRef][Medline]
14 - McCloskey, T. W., V. Haridas, R. Pahwa, and S. Pahwa. 2002. T cell receptor Vß repertoire of the antigen specific CD8 T lymphocyte subset of HIV infected children. AIDS 16:1459-1465.[CrossRef][Medline]
15 - Mongkolsapaya, J., A. Jaye, M. F. C. Callan, A. F. Magnusen, A. J. McMichael, and H. C. Whittle. 1999. Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J. Virol. 73:67-71.[Abstract/Free Full Text]
16 - Neisig, A., A. Vangsted, J. Zeuthen, and C. Geisler. 1993. Assembly of the T cell antigen receptor. J. Immunol. 151:870-879.[Abstract]
17 - Niehues, T., T. W. McCloskey, J. Ndagijimana, G. Horneff, V. Wahn, and S. Pahwa. 2001. Apoptosis in T-lymphocyte subsets in human immunodeficiency virus-infected children measured immediately ex vivo and following in vitro activation. Clin. Diagn. Lab. Immunol. 8:74-78.[Abstract/Free Full Text]
18 - Pahwa, S. 1988. HIV infection in children: nature of immunodeficiency, clinical spectrum, and management. Ped. Infect. Dis. J. 7:S61-S71.
19 - Pantaleo, G., J. F. Demarest, H. Soudeyns, C. Graziosi, F. Denis, J. W. Adelsberger, P. Borrow, M. S. Saag, G. M. Shaw, R. P. Sekaly, and A. S. Fauci. 1994. Major expansions of CD8+ T cells with predominant Vß usage during the primary immune response to HIV. Nature 370:463-467.[CrossRef][Medline]
20 - Posnett, D. N., S. Kabak, A. S. Hodtsev, E. A. Goldberg, and A. Asch. 1993. T cell antigen receptor Vß subsets are not preferentially deleted in AIDS. AIDS 7:625-631.[Medline]
21 - Rebai, N., G. Pantaleo, J. F. Demarest, C. Ciurli, H. Soudeyns, J. W. Adelsberger, M. Vaccarezza, R. E. Walker, R. P. Sekaly, and A. S. Fauci. 1994. Analysis of the T-cell receptor ß-chain variable region (Vß) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific Vß segments in CD4+ T cells of the virus-positive twins. Proc. Natl. Acad. Sci. USA 91:1529-1533.[Abstract/Free Full Text]
22 - Soudeyns, H., P. Champagne, C. L. Holloway, G. U. Silvestri, N. Ringuette, J. Samson, N. Lapointe, and R. P. Sekaly. 2000. Transient T cell receptor ß-chain variable region-specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection: characterization of expanded cell populations by T cell receptor phenotyping. J. Infect. Dis. 181:107-120.[CrossRef][Medline]
23 - Soudeyns, H., N. Rebai, G. Pantaleo, C. Ciurli, T. Boghossian, R. P. Sekaly, and A. S. Fauci. 1993. The T cell receptor Vß repertoire in HIV-1 infection and disease. Semin. Immunol. 5:175-185.[CrossRef][Medline]
24 - Spencer, J. V., and T. J. Braciale. 2000. Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. J. Exp. Med. 191:1687-1698.[Abstract/Free Full Text]
25 - Than, S., M. Kharbanda, V. Chitnis, S. Bakshi, P. K. Gregersen, and S. Pahwa. 1999. Clonal dominance pattern of CD8 T cells in relation to disease progression in HIV-infected children. J. Immunol. 162:3680-3686.[Abstract/Free Full Text]
26 - Wilson, J. K. D., G. S. Ogg, R. L. Allen, P. J. R. Goulder, A. Kelleher, A. K. Sewell, C. A. O'Callaghan, S. L. Rowland-Jones, M. F. C. Callan, and A. J. McMichael. 1998. Oligoclonal expansions of CD8+ T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188:785-790.[Abstract/Free Full Text]
27 - Zajac, A. J., J. N. Blattman, K. Murali-Krishna, et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.[Abstract/Free Full Text]
28 - Zeng, W., S. Nakao, H. Takamatsu, A. Yachie, A. Takami, Y. Kondo, N. Sugimori, H. Yamazaki, Y. Miura, S. Shiobara, and T. Matsuda. 1999. Characterization of T-cell repertoire of the bone marrow in immune-mediated aplastic anemia: evidence for the involvement of antigen-driven T-cell response in cyclosporine-dependent aplastic anemia. Blood 93:3008-3016.[Abstract/Free Full Text]
Clinical and Diagnostic Laboratory Immunology, January 2003, p. 53-58, Vol. 10, No. 1
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.1.53-58.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Fernandes, S., Chavan, S., Chitnis, V., Kohn, N., Pahwa, S.
(2005). Simplified Fluorescent Multiplex PCR Method for Evaluation of the T-Cell Receptor V{beta}-Chain Repertoire. CVI
12: 477-483
[Abstract]
[Full Text]